Discussion of the Committee on Daubert Standards :: summary of meetings /

In 1993, the U.S. Supreme Court in Daubert v. Merrell Dow Pharmaceuticals, Inc., laid out a new test for federal trial judges to use when determining the admissibility of expert testimony. In Daubert, the Court ruled that judges should act as gatekeepers, assessing the reliability of the scientific...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Hanna, Kathi E.
Körperschaft: National Research Council (U.S.). Committee on Daubert Standards
Weitere Verfasser: Mazza, Anne-Marie
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Washington, D.C. : National Academies Press, 2006.
Schlagworte:
Online-Zugang:Volltext
Zusammenfassung:In 1993, the U.S. Supreme Court in Daubert v. Merrell Dow Pharmaceuticals, Inc., laid out a new test for federal trial judges to use when determining the admissibility of expert testimony. In Daubert, the Court ruled that judges should act as gatekeepers, assessing the reliability of the scientific methodology and reasoning that supports expert testimony. The resulting judicial screening of expert testimony has been particularly consequential. While the Supreme Court sought to bring better science into the courtroom, questions remain about whether the lower courts' application of Daubert accords with scientific practices. This report summarizes discussions held by an ad hoc committee of the The National Academies to consider the impact of Daubert and subsequent Supreme Court opinions and to identify questions for future study.
Beschreibung:1 online resource (ix, 35 pages)
Bibliographie:Includes bibliographical references (page 21).
ISBN:0309662494
9780309662499
1280567333
9781280567339
0309181100
9780309181105
9786610567331
6610567336

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Volltext öffnen